NFE2L2 and cancer: Leveraging gene expression data for 9801 tumors representing 32 cancer types from the Cancer Genome Atlas (TCGA), we demonstrated that elevated KYNU parallels increased gene-based signatures of NRF2 activation and that elevated tumoral KYNU mRNA expression is strongly associated with an immunosuppressive tumor microenvironment regardless of the cancer type.